November 21, 2011
Two Bayer AG units reached a settlement with Teva Pharmaceuticals USA Inc. over two erectile dysfunction patents, ending the five cases Bayer launched to prevent Teva's bid to make a generic version of its drug Levitra, according to a consent judgment filed Monday.